Elehear Beyond vs Signia Pure C&G IX

The Elehear Beyond is a budget-priced OTC hearing aid that delivers A-grade performance in our lab testing, ranking #8 among 65 OTC hearing aids tested. At $431, this 2024 behind-the-ear device earned our Expert's Choice Award and represents strong value in the entry-level price tier. In our testing, the Beyond demonstrated particular strength in speech clarity in quiet environments, scoring 4.3/5—a strong result that sits 1.48 points above the OTC category average. Music streaming quality also impressed at 3.8/5, exceeding the category average by 1.88 points. Speech understanding in noisy settings scored 2.3/5, which is above the category average of 1.48/5 but remains mixed in absolute terms—a common challenge across OTC devices. Feedback handling proved excellent at 4.5/5, essentially matching the category average. Own-voice comfort scored 2.6/5, slightly above the OTC average but mixed overall—users sensitive to their own voice may notice some occlusion effects. The device uses a rechargeable battery and supports streaming to both iPhone and Android devices with hands-free functionality. The Elehear Beyond is well-suited for budget-conscious consumers seeking reliable speech clarity in quieter listening situations and quality audio streaming. Those who frequently encounter challenging noise environments may find the speech-in-noise performance adequate but not exceptional. Within its price range, the Beyond outperforms competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni on overall sound quality.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.